Coronavirus Disease 19 and Severe Acute Respiratory Syndrome Coronavirus 2: To More Efficient Control

Otmane El Brini
Additional contact information
Otmane El Brini: Ibn Tofail University, Morocco.

European Journal of Biology and Biotechnology, 2020, vol. 1, issue 3

Abstract: The coronavirus disease 19 (COVID-19) is a viral infection caused by a new coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is considered as a public health emergency of international concern. The only available way, apparently effective, to control this pandemic is the social distancing. However, other possible aspects of infection control may be mentioned. In this review, we highlight certain peculiarities linked to the nature of the virus and its angiotensin converting enzyme 2 receptor, the host defense and the final clinical manifestation of the infection that could be essential elements in strengthening the effectiveness of COVID-19 pandemic control efforts.

Keywords: Severe acute respiratory syndrome coronavirus 2; Coronavirus disease 19; Angiotensin converting enzyme 2; Pandemic. (search for similar items in EconPapers)
Date: 2020
References: Add references at CitEc
Citations:

Downloads: (external link)
https://eu-opensci.org/index.php/ejbio/article/view/17029 Abstract page (text/html)
https://eu-opensci.org/index.php/ejbio/article/download/17029/4103 Full text (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:epw:ejbio0:v:1:y:2020:i:3:id:17029

DOI: 10.24018/ejbio.2020.1.3.29

Access Statistics for this article

More articles in European Journal of Biology and Biotechnology from European Open Science
Bibliographic data for series maintained by Support Team ().